Undertaking for non-applicability disclosure for RPT under Regulation 23 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has submitted an undertaking to BSE on May 23, 2025, stating that the Related Party Transactions (RPT) disclosure requirement under Regulation 23 of SEBI (LODR) Regulations, 2015 is not applicable to the company. This applies for the half year and financial year ended March 31, 2025. The company explained that it is listed on the SME platform of BSE Limited and does not exceed the threshold limits specified for such disclosure. Accordingly, the company is exempt under Regulation 15 of SEBI (LODR) Regulations, 2015. The letter is signed by Jagdish Umakant Nayak, Chairman and Managing Director (DIN: 00646672).
This is a routine compliance filing with no material impact on shareholders or stock price. It simply confirms that as an SME-listed entity, the company is exempt from detailed RPT disclosure norms that apply to larger listed companies.